Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DUBLIN, Ireland and TREVOSE, Pa., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
-
DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
-
~ Achieved Net Product Sales of $2.5 Million for KEVEYIS® (dichlorphenamide), a 67% Revenue Growth Increase over the Previous Quarter ~ ~ Increasing Commercial Investment in KEVEYIS with Expansion of...
-
DUBLIN, Ireland and TREVOSE, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
-
DUBLIN, Ireland and TREVOSE, Pa., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
-
DUBLIN, Ireland and TREVOSE, Pa., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced the closing of its previously announced underwritten...
-
DUBLIN, Ireland and TREVOSE, Pa., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it has priced its previously announced underwritten...
-
DUBLIN, Ireland and TREVOSE, Pa., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it intends to offer and sell its ordinary shares in...
-
DUBLIN, Ireland and TREVOSE, Pa., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the...
-
DUBLIN, Ireland and TREVOSE, Pa, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...